Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Mayr

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2017
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibitionBernd Kubista, Thomas Schoefl, Lisa Mayr, et al.
Pediatric Blood & Cancer|October 29, 2022
Viral infections in pediatric brain tumor patients treated with targeted therapiesLisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, et al.
Pediatric Blood & Cancer|May 29, 2023
Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapiesLisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, et al.
Pediatric Blood & Cancer|January 25, 2023
Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapiesLisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2015
EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistanceFlorian Sevelda, Lisa Mayr, Bernd Kubista, et al.
Cytokine|May 23, 2020
Gastric banding-associated weight loss diminishes hepatic Tsukushi expressionChristoph Grander, Nikolai Jaschke, Barbara Enrich, et al.
Paediatric Drugs|April 8, 2024
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain TumorsIris K Minichmayr, Ursula Knaack, Johannes Gojo, et al.
Gut|August 24, 2023
Inflammatory bowel disease in STAT1 gain-of-function immunodeficiency treated with precision medicineJulian Schwärzler, Andreas Zollner, Theresa Dolejsi, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 18, 2021
Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver InjuryChristoph Grander, Felix Grabherr, Barbara Enrich, et al.
Pediatric Blood & Cancer|January 4, 2024
Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patientsNatalia Stepien, Lisa Mayr, Maria T Schmook, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2017
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibitionBernd Kubista, Thomas Schoefl, Lisa Mayr, et al.
Pediatric Blood & Cancer|October 29, 2022
Viral infections in pediatric brain tumor patients treated with targeted therapiesLisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, et al.
Pediatric Blood & Cancer|May 29, 2023
Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapiesLisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, et al.
Pediatric Blood & Cancer|January 25, 2023
Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapiesLisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 4, 2015
EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistanceFlorian Sevelda, Lisa Mayr, Bernd Kubista, et al.
Cytokine|May 23, 2020
Gastric banding-associated weight loss diminishes hepatic Tsukushi expressionChristoph Grander, Nikolai Jaschke, Barbara Enrich, et al.
Paediatric Drugs|April 8, 2024
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain TumorsIris K Minichmayr, Ursula Knaack, Johannes Gojo, et al.
Gut|August 24, 2023
Inflammatory bowel disease in STAT1 gain-of-function immunodeficiency treated with precision medicineJulian Schwärzler, Andreas Zollner, Theresa Dolejsi, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 18, 2021
Hepatic Meteorin-like and Krüppel-like Factor 3 are Associated with Weight Loss and Liver InjuryChristoph Grander, Felix Grabherr, Barbara Enrich, et al.
Pediatric Blood & Cancer|January 4, 2024
Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patientsNatalia Stepien, Lisa Mayr, Maria T Schmook, et al.
Pageof 7